Biocon's contract research arm Syngene International today reported a 11.54 per cent rise in standalone net profit to Rs 74.4 crore for the quarter ended December 31, 2016.
The company had posted a net profit of Rs 66.7 crore in the year-ago period, Syngene International said in a filing to BSE.
Its total standalone income from operations also rose to Rs 332.1 crore during the quarter under review as against Rs 280.4 crore a year ago.
"We made good progress on client service delivery across all of business verticals despite a fire incident damaging one of our research facilities, effective implementation of our business continuity plan and continued normal operations of all our other facilities helped minimise the impact of the incident on our overall earnings for the quarter," Syngene International CEO Jonathan Hunt said.
Shares of the company today closed 1.42 per cent down at at Rs 565.35 apiece on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
